Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Honeywell may just be the next conglomerate to split into various pieces. At least if Elliott Investment Management has its way.
A treasure trove of genetic data may hold the key to a revolution in drug development, but it offers no clues for building a business.
Shell managed to overturn a Dutch legal order made in 2021 that had mandated the company cut its emissions 45% from 2019 levels by 2030.